Catatan efek · kuartal yang diarsipkan
BEAM
Beam Therapeutics Inc. · Healthcare · Biotechnology
14Pemegang yang dilacak
0Δ pemegang
51.27MSaham yang dipegang
$872.17MNilai yang dilaporkan
+1Posisi baru
−1Keluar
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -0.1% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | +9 | 71.47M | $2.45B | +12 | −3 |
| Q1 2026 | 92 | +3 | 70.17M | $1.67B | +9 | −6 |
| Q4 2025 | 89 | +3 | 73.41M | $2.04B | +4 | −1 |
| Q3 2025 | 16 | -1 | 52.77M | $1.28B | +1 | −2 |
| Q2 2025 | 14 | 0 | 51.27M | $872.17M | +1 | −1 |
| Q1 2025 | 11 | -2 | 20.67M | $403.69M | — | −2 |
| Q4 2024 | 13 | +2 | 16.59M | $411.47M | +3 | −1 |
| Q3 2024 | 10 | -1 | 11.89M | $291.41M | — | −1 |
| Q2 2024 | 11 | — | 12.82M | $300.27M | — | — |
Siapa yang memegangnya · Q2 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 12.96M | — | $220.47M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 12.96M | — | $220.47M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 12.96M | — | $220.47M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 12.96M | — | $220.47M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 12.96M | — | $220.47M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 12.96M | — | $220.47M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | The Vanguard Group ✦ (pasif) | 9.71M | — | $165.10M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | The Vanguard Group ✦ (pasif) | 9.71M | — | $165.10M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (pasif) | 9.71M | — | $165.10M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (pasif) | 9.71M | — | $165.10M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (pasif) | 9.71M | — | $165.10M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (pasif) | 9.71M | — | $165.10M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | ARK Investment Management ✦ | 8.85M | +4.3% | $150.50M | 1.1% | ▲ Add | 5 | SEC ↗ |
| 14 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | BlackRock ✦ (pasif) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | State Street Global Advisors ✦ (pasif) | 3.64M | +5.8% | $61.89M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 31 | T. Rowe Price ✦ | 2.44M | -19.3% | $41.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | T. Rowe Price ✦ | 2.44M | -19.3% | $41.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Citadel Advisors ✦ | 2.34M | -6.5% | $39.76M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 2.34M | -6.5% | $39.76M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Geode Capital Management ✦ (pasif) | 2.25M | +2.5% | $38.35M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Geode Capital Management ✦ (pasif) | 2.25M | +2.5% | $38.35M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Two Sigma Investments ✦ | 561.52K | +52.1% | $9.55M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Baillie Gifford ✦ | 300.14K | -0.9% | $5.11M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Baillie Gifford ✦ | 300.14K | -0.9% | $5.11M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | Baillie Gifford ✦ | 300.14K | -0.9% | $5.11M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | Marshall Wace ✦ | 99.96K | -62.9% | $1.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 42 | Millennium Management ✦ | 58.20K | +59.5% | $990,050 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 43 | Wellington Management ✦ | 37.27K | +10.8% | $633,912 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | Wellington Management ✦ | 37.27K | +10.8% | $633,912 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Wellington Management ✦ | 37.27K | +10.8% | $633,912 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | Wellington Management ✦ | 37.27K | +10.8% | $633,912 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 25.42K | Baru | $432,411 | 0.0% | New | 1 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 25.42K | Baru | $432,411 | 0.0% | New | 1 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 25.42K | Baru | $432,411 | 0.0% | New | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| AQR Capital Management | $432,411 | 0.0% |
| AQR Capital Management | $432,411 | 0.0% |
| AQR Capital Management | $432,411 | 0.0% |
Telah keluar
| Renaissance Technologies | $236,450 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 248 pemegang, 107.79M saham, $2.49B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q2 2025 ·
Metodologi ·
Dapatkan ini melalui API